Skip to main content
PMC home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1986 May;53(5):637–642. doi: 10.1038/bjc.1986.107

gamma-Glutamyltranspeptidase activity in human breast lesions: an unfavourable prognostic sign.

S Bard, P Noël, F Chauvin, G Quash
PMCID: PMC2001394  PMID: 2872909

Abstract

The activity of gamma-glutamyltranspeptidase (gamma GT) (EC 2.3.2.2) was examined by histoenzymatic labelling on frozen sections derived from normal breast tissue, benign lesions and carcinomas. In biopsies from normal tissue and benign lesions, labelling was very intense in lumina and in the apical pole of the cells lining the lumina whilst in the cytoplasm it was slightly positive. In 34 out of 70 carcinomas, gamma GT activity was either undetectable or slightly positive while in the remaining 36 there was intense activity. Statistical examination of the results revealed no obvious correlation of gamma GT activity with histological grade of the tumour, progesterone receptor content or classification of patients by pre- or postmenopausal status. A good correlation between gamma GT activity and the following unfavourable prognostic signs: lymph node metastases and absence of oestradiol receptors. Patients with gamma GT-negative tumours may have a more favourable prognosis than those with gamma GT-positive tumours.

Full text

PDF
637

Images in this article

638Figure 1
on p.638
639Figure 2
on p.639
639Figure 3
on p.639
639Figure 4
on p.639
639Figure 5
on p.639

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Almersjö O., Bengmark S., Hafström L. Liver metastases found by follow-up of patients operated on for colorectal cancer. Cancer. 1976 Mar;37(3):1454–1457. doi: 10.1002/1097-0142(197603)37:3<1454::aid-cncr2820370329>3.0.co;2-d. [DOI] [PubMed] [Google Scholar]
  2. BLOOM H. J., RICHARDSON W. W. Histological grading and prognosis in breast cancer; a study of 1409 cases of which 359 have been followed for 15 years. Br J Cancer. 1957 Sep;11(3):359–377. doi: 10.1038/bjc.1957.43. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Beck P. R., Belfield A., Spooner R. J., Blumgart L. H., Wood C. B. Serum enzymes in colorectal cancer. Cancer. 1979 May;43(5):1772–1776. doi: 10.1002/1097-0142(197905)43:5<1772::aid-cncr2820430529>3.0.co;2-y. [DOI] [PubMed] [Google Scholar]
  4. Bridges R. J., Meister A. gamma-Glutamyl amino acids. Transport and conversion to 5-oxoproline in the kidney. J Biol Chem. 1985 Jun 25;260(12):7304–7308. [PubMed] [Google Scholar]
  5. Cameron R., Kellen J., Kolin A., Malkin A., Farber E. Gamma-glutamyltransferase in putative premalignant liver cell populations during hepatocarcinogenesis. Cancer Res. 1978 Mar;38(3):823–829. [PubMed] [Google Scholar]
  6. Cooper E. H., Turner R., Steele L., Neville A. M., Mackay A. M. The contribution of serum enzymes and carcinoembryonic antigen to the early diagnosis of metastatic colorectal cancer. Br J Cancer. 1975 Jan;31(1):111–117. doi: 10.1038/bjc.1975.13. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. De Young L. M., Richards W. L., Bonzelet W., Tsai L. L., Boutwell R. K. Localization and significance of gamma-glutamyltranspeptidase in normal and neoplastic mouse skin. Cancer Res. 1978 Nov;38(11 Pt 1):3697–3701. [PubMed] [Google Scholar]
  8. Fiala S., Mohindru A., Kettering W. G., Fiala A. E., Morris H. P. Glutathione and gamma glutamyl transpeptidase in rat liver during chemical carcinogenesis. J Natl Cancer Inst. 1976 Sep;57(3):591–598. doi: 10.1093/jnci/57.3.591. [DOI] [PubMed] [Google Scholar]
  9. Hawkins R. A., Roberts M. M., Forrest A. P. Oestrogen receptors and breast cancer: current status. Br J Surg. 1980 Mar;67(3):153–169. doi: 10.1002/bjs.1800670302. [DOI] [PubMed] [Google Scholar]
  10. Hirota N., Williams G. M. The sensitivity and heterogeneity of histochemical markers for altered foci involved in liver carcinogenesis. Am J Pathol. 1979 May;95(2):317–328. [PMC free article] [PubMed] [Google Scholar]
  11. Horwitz K. B., McGuire W. L. Specific progesterone receptors in human breast cancer. Steroids. 1975 Apr;25(4):497–505. doi: 10.1016/0039-128x(75)90027-6. [DOI] [PubMed] [Google Scholar]
  12. Jaken S., Mason M. Differences in the isoelectric focusing patterns of gamma-glutamyl transpeptidase from normal and cancerous rat mammary tissue. Proc Natl Acad Sci U S A. 1978 Apr;75(4):1750–1753. doi: 10.1073/pnas.75.4.1750. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Klein-Szanto A. J., Nelson K. G., Shah Y., Slaga T. J. Simultaneous appearance of keratin modifications and gamma-glutamyltransferase activity as indicators of tumor progression in mouse skin papillomas. J Natl Cancer Inst. 1983 Jan;70(1):161–168. [PubMed] [Google Scholar]
  14. Knight W. A., Livingston R. B., Gregory E. J., McGuire W. L. Estrogen receptor as an independent prognostic factor for early recurrence in breast cancer. Cancer Res. 1977 Dec;37(12):4669–4671. [PubMed] [Google Scholar]
  15. Levine S. E., Budwit D. A., Michalopoulos G. K., Georgiade G. S., McCarty K. S., Jr gamma-Glutamyl transpeptidase activity in benign and malignant human mammary epithelial lesions. Histochemical evaluation. Arch Pathol Lab Med. 1983 Aug;107(8):423–427. [PubMed] [Google Scholar]
  16. Marathe G. V., Nash B., Haschemeyer R. H., Tate S. S. Ultrastructural localization of gamma-glutamyl transpeptidase in rat kidney and jejunum. FEBS Lett. 1979 Nov 15;107(2):436–440. doi: 10.1016/0014-5793(79)80425-1. [DOI] [PubMed] [Google Scholar]
  17. McGuire W. L., Clark G. M. Progesterone receptors and human breast cancer; 'Wassink lecture' presented at the 3rd EORTC Breast Cancer Working Conference. Eur J Cancer Clin Oncol. 1983 Dec;19(12):1681–1685. doi: 10.1016/0277-5379(83)90152-9. [DOI] [PubMed] [Google Scholar]
  18. Meister A., Anderson M. E. Glutathione. Annu Rev Biochem. 1983;52:711–760. doi: 10.1146/annurev.bi.52.070183.003431. [DOI] [PubMed] [Google Scholar]
  19. Munjal D., Chawla P. L., Lokich J. J., Zamcheck N. Carcinoembryonic antigen and phosphohexose isomerase, gammaglutamyl transpeptidase and lactate dehydorgenase levels in patients with and without liver metastases. Cancer. 1976 Apr;37(4):1800–1807. doi: 10.1002/1097-0142(197604)37:4<1800::aid-cncr2820370426>3.0.co;2-k. [DOI] [PubMed] [Google Scholar]
  20. Nemoto T., Vana J., Bedwani R. N., Baker H. W., McGregor F. H., Murphy G. P. Management and survival of female breast cancer: results of a national survey by the American College of Surgeons. Cancer. 1980 Jun 15;45(12):2917–2924. doi: 10.1002/1097-0142(19800615)45:12<2917::aid-cncr2820451203>3.0.co;2-m. [DOI] [PubMed] [Google Scholar]
  21. Osuji G. O. The kinetics of the gamma-glutamyl cycle-mediated uptake of amino acids: considerations explaining the bifurcation of the gamma-glutamyl cycle. FEBS Lett. 1980 Feb 11;110(2):192–194. doi: 10.1016/0014-5793(80)80070-6. [DOI] [PubMed] [Google Scholar]
  22. Pocius P. A., Baumrucker C. R., McNamara J. P., Bauman D. E. gamma-Glutamyl transpeptidase in rat mammary tissue. Activity during lactogenesis and regulation by prolactin. Biochem J. 1980 May 15;188(2):565–568. doi: 10.1042/bj1880565. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Puente J., Varas M. A., Beckhaus G., Sapag-Hagar M. Gamma-glutamyltranspeptidase activity and cyclic AMP levels in rat liver and mammary gland during the lactogenic cycle and in the oestradiol-progesterone pseudo-induced pregnancy. FEBS Lett. 1979 Mar 1;99(1):215–218. doi: 10.1016/0014-5793(79)80282-3. [DOI] [PubMed] [Google Scholar]
  24. Ranson J. H., Adams P. X., Localio S. A. Preoperative assessment for hepatic metastases in carcinoma of the colon and rectum. Surg Gynecol Obstet. 1973 Sep;137(3):435–438. [PubMed] [Google Scholar]
  25. Rich M. A., Furmanski P., Brooks S. C. Prognostic value of estrogen receptor determinations in patients with breast cancer. Cancer Res. 1978 Nov;38(11 Pt 2):4296–4298. [PubMed] [Google Scholar]
  26. Rutenburg A. M., Kim H., Fischbein J. W., Hanker J. S., Wasserkrug H. L., Seligman A. M. Histochemical and ultrastructural demonstration of gamma-glutamyl transpeptidase activity. J Histochem Cytochem. 1969 Aug;17(8):517–526. doi: 10.1177/17.8.517. [DOI] [PubMed] [Google Scholar]
  27. Saez S., Cheix F., Asselain B. Prognostic value of estrogen and progesterone receptors in primary breast cancer. Breast Cancer Res Treat. 1983;3(4):345–353. doi: 10.1007/BF01807587. [DOI] [PubMed] [Google Scholar]
  28. Tate S. S., Meister A. Serine-borate complex as a transition-state inhibitor of gamma-glutamyl transpeptidase. Proc Natl Acad Sci U S A. 1978 Oct;75(10):4806–4809. doi: 10.1073/pnas.75.10.4806. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES